INVASIVE BREAST CARCINOMA OF NO SPECIAL TYPE

Clinical trials for INVASIVE BREAST CARCINOMA OF NO SPECIAL TYPE explained in plain language.

Never miss a new study

Get alerted when new INVASIVE BREAST CARCINOMA OF NO SPECIAL TYPE trials appear

Sign up with your email to follow new studies for INVASIVE BREAST CARCINOMA OF NO SPECIAL TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Gene test could predict which breast cancers resist common drug

Knowledge-focused Recruiting now

This study aims to understand if a specific gene mutation (HSD3B1) makes the breast cancer drug letrozole less effective. Postmenopausal women with early-stage, hormone-sensitive breast cancer will take letrozole for a few weeks before their standard surgery. Researchers will com…

Matched conditions: INVASIVE BREAST CARCINOMA OF NO SPECIAL TYPE

Phase: PHASE4 • Sponsor: University of Washington • Aim: Knowledge-focused

Last updated Mar 24, 2026 12:02 UTC

INVASIVE BREAST CARCINOMA OF NO SPECIAL TYPE

Get alerted when new INVASIVE BREAST CARCINOMA OF NO SPECIAL TYPE trials appear

Gene test could predict which breast cancers resist common drug